← Alle mensen

SD

Stephane Dalle

7 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Nivolumab plus relatlimab in gevorderd melanoma: RELATIVITY-047 4-year update.

European journal of cancer (Oxford, England : 1990) · 25 juli 2025

Gerandomiseerde, Open-Label, Fase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 mei 2025

Outcomes With Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024-11

Adjuvant nivolumab versus ipilimumab bij melanoom: CheckMate 238 vierjaars herbeoordeling

European journal of cancer (Oxford, England : 1990) · 2022-09

Adjuvant nivolumab versus ipilimumab bij melanoom: CheckMate 238 vierjaars

The Lancet. Oncology · 2020-11

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab bij melanoom: ECHO-301/KEYNOTE-252

The Lancet. Oncology · 2019-08

Mogamulizumab versus vorinostat bij eerder behandeld cutaan T-cellymfoom: MAVORIC fase III

The Lancet. Oncology · 2018-09